Search research articles
Contact Us
Filters
Showing results (11-20 of 24) with videos related to
Page
of 3
Sort By:
Sexually Transmitted Infections
|
October 24, 2003
A population based dynamic approach for estimating the cost effectiveness of screening for Chlamydia trachomatis
R Welte, M Kretzschmar, J A R van den Hoek, et al.
Sexually Transmitted Infections
|
March 2, 2002
Comparing cost effectiveness of screening women for Chlamydia trachomatis in systematic and opportunistic approaches
M J Postma, R Welte, J A R van den Hoek, et al.
Vaccine
|
September 25, 2001
Health economics of a hexavalent meningococcal outer-membrane vesicle vaccine in children: potential impact of introduction in the Dutch vaccination program
J M Bos, H C Rümke, R Welte, et al.
Health Services Management Research
|
May 13, 2022
Association between asthma control and healthcare costs: Results from a German linked data study
Thomas Wilke, Hartmut Timmermann, Sabrina Mueller, et al.
Vaccine
|
January 22, 2019
The cost-of-illness for invasive meningococcal disease caused by serogroup B Neisseria meningitidis (MenB) in Germany
Stefan Scholz, Florian Koerber, Kinga Meszaros, et al.
Sexually Transmitted Diseases
|
October 18, 2000
Cost-effectiveness of screening programs for Chlamydia trachomatis: a population-based dynamic approach
R Welte, M Kretzschmar, R Leidl, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
September 29, 2004
Do costs of varicella justify routine infant vaccination? Pharmacoeconomic and clinical considerations
M J Postma, J M Bos, R Welte, et al.
Nederlands Tijdschrift Voor Geneeskunde
|
December 11, 1999
[Opportunistic screening for genital infections with Chlamydia trachomatis among the sexually active population in Amsterdam. III. Cost-effectiveness analysis of screening women and the role of reinfection and partner treatment]
M J Postma, R Welte, J A van den Hoek, et al.
Nederlands Tijdschrift Voor Geneeskunde
|
May 13, 1999
[Opportunistic screening for genital infections with Chlamydia trachomatis in sexually active population of Amsterdam. II. Cost-effectiveness analysis of screening women]
M J Postma, R Welte, J A van den Hoek, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
November 14, 2001
Cost-effectiveness of partner pharmacotherapy in screening women for asymptomatic infection with Chlamydia Trachomatis
M J Postma, R Welte, J A van den Hoek, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 24) with videos related to
Sort By:
Page
of 3
Sexually Transmitted Infections
|
October 24, 2003
A population based dynamic approach for estimating the cost effectiveness of screening for Chlamydia trachomatis
R Welte, M Kretzschmar, J A R van den Hoek, et al.
Sexually Transmitted Infections
|
March 2, 2002
Comparing cost effectiveness of screening women for Chlamydia trachomatis in systematic and opportunistic approaches
M J Postma, R Welte, J A R van den Hoek, et al.
Vaccine
|
September 25, 2001
Health economics of a hexavalent meningococcal outer-membrane vesicle vaccine in children: potential impact of introduction in the Dutch vaccination program
J M Bos, H C Rümke, R Welte, et al.
Health Services Management Research
|
May 13, 2022
Association between asthma control and healthcare costs: Results from a German linked data study
Thomas Wilke, Hartmut Timmermann, Sabrina Mueller, et al.
Vaccine
|
January 22, 2019
The cost-of-illness for invasive meningococcal disease caused by serogroup B Neisseria meningitidis (MenB) in Germany
Stefan Scholz, Florian Koerber, Kinga Meszaros, et al.
Sexually Transmitted Diseases
|
October 18, 2000
Cost-effectiveness of screening programs for Chlamydia trachomatis: a population-based dynamic approach
R Welte, M Kretzschmar, R Leidl, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
September 29, 2004
Do costs of varicella justify routine infant vaccination? Pharmacoeconomic and clinical considerations
M J Postma, J M Bos, R Welte, et al.
Nederlands Tijdschrift Voor Geneeskunde
|
December 11, 1999
[Opportunistic screening for genital infections with Chlamydia trachomatis among the sexually active population in Amsterdam. III. Cost-effectiveness analysis of screening women and the role of reinfection and partner treatment]
M J Postma, R Welte, J A van den Hoek, et al.
Nederlands Tijdschrift Voor Geneeskunde
|
May 13, 1999
[Opportunistic screening for genital infections with Chlamydia trachomatis in sexually active population of Amsterdam. II. Cost-effectiveness analysis of screening women]
M J Postma, R Welte, J A van den Hoek, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
November 14, 2001
Cost-effectiveness of partner pharmacotherapy in screening women for asymptomatic infection with Chlamydia Trachomatis
M J Postma, R Welte, J A van den Hoek, et al.
Page
of 3